2018
DOI: 10.1016/j.canlet.2018.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Antitumor activity of nanoliposomes encapsulating the novobiocin analog 6BrCaQ in a triple-negative breast cancer model in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 33 publications
0
5
0
Order By: Relevance
“…Three liposomal formulations were prepared as shown in Table 1 using the thin film hydration method as reported previously (Sauvage et al, 2018). The first formulation was the non-PEGylated one that was composed of HSPC and cholesterol in a ratio 60:40, loaded with oleuropein.…”
Section: Preparation Of Nanoliposomes (Nanophytosome)mentioning
confidence: 99%
“…Three liposomal formulations were prepared as shown in Table 1 using the thin film hydration method as reported previously (Sauvage et al, 2018). The first formulation was the non-PEGylated one that was composed of HSPC and cholesterol in a ratio 60:40, loaded with oleuropein.…”
Section: Preparation Of Nanoliposomes (Nanophytosome)mentioning
confidence: 99%
“…Although the previous systems encapsulated a N-terminal inhibitor, we developed a liposomal system in which a C-terminal inhibitor 6-BrCaQ [ 116 , 117 ] has been encapsulated as well. It has been encapsulated in liposomes and administered in vivo to mice bearing a triple negative breast cancer model.…”
Section: Will a Combination Of Both Hsp90 Inhibition And The Use Of D...mentioning
confidence: 99%
“…They are classified as Hsp27, Hsp40, Hsp60, Hsp70, Hsp90, and Hsp105 based on their molecular weights [ 3 ]. The anti-apoptotic function of Hsp70 and Hsp90 had been suggested to be one of the major mechanisms of chemotherapeutic agent resistance on cancer cells [ 4 , 5 ]. Therefore, several Hsp70 and Hsp90 inhibitors are anticancer agents.…”
Section: Introductionmentioning
confidence: 99%